Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioventus Inc BVS

Healthcare Medical Instruments & Supplies
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

NDAQ:BVS - Post Discussion

Bioventus Inc > $BVS Shareholder Suit Survives Motion to Dismiss
View:
Post by JGrabar on Nov 08, 2023 8:42am

$BVS Shareholder Suit Survives Motion to Dismiss

On 11/23, by order of the U.S. District Court for the Middle District of North Carolina, the Defendants’ motion to dismiss the second amended complaint was denied, and the Plaintiffs Exchange Act claims under § 10(b) and § 20(a) were allowed proceed. $BVS
https://grabarlaw.com/the-latest/bioventus-shareholder-investigation/
Be the first to comment on this post
Bioventus Inc